CDCA1-ABGELEITETES PEPTID UND IMPFSTOFF DAMIT

Patent europeic · EP3178839 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3178839
Numer da la dumonda
EP15830292
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
31-07-2015
Publitgà
14-06-2017
Concedì
04-10-2023
Stritgà
25-02-2025
Motiv
Taxa annuala betg pajada
Classas IPC
C07K 7/06 (2006.01)
A61K 35/12 (2015.01)
A61K 35/14 (2015.01)
A61K 38/00 (2006.01)
A61K 39/395 (2006.01)
A61K 48/00 (2006.01)
C12N 5/10 (2006.01)
C12N 15/09 (2006.01)
C07K 7/08 (2006.01)
C07K 16/28 (2006.01)
Prioritad
JP 2014158922 04.08.2014
JP 2014158923 04.08.2014
JP 2014158924 04.08.2014
Dumonda PCT
PCT/JP2015/071832 31.07.2015
Publicaziun PCT
WO2016/021508 11.02.2016
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-02-2025

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    25.02.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 25.02.2025

  2. 14-08-2024

    Midada

    Published in Swissreg on 14.08.2024

  3. 04-10-2023

    Concedì

    Published in Swissreg on 04.10.2023

Partidas

Possessur

OncoTherapy Science, Inc.

2-1, Sakado 3-chome, Takatsu-ku, Kawasaki-shi Kanagawa 213-0012, JP

Inventur

OSAWA, Ryuji

Kawasaki-shi Kanagawa 213-0012, JP

WATANABE, Tomohisa

Kawasaki-shi Kanagawa 213-0012, JP

TSUNODA, Takuya

Kawasaki-shi Kanagawa 213-0012, JP

YAMASHITA, Sachiko

Kawasaki-shi Kanagawa 213-0012, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.